Email Alert | RSS

Journal of Peking University (Health Sciences) ›› 2022, Vol. 54 ›› Issue (4): 774-778. doi: 10.19723/j.issn.1671-167X.2022.04.032

Previous Articles     Next Articles

茁 刘1,国栋 朱1,世英 唐1,鹏 洪1,勋 赵1,启鸣 张1,丽伟 李2,冉 彭3,志刚 陈1,滨帅 王1,丽 张2,飞龙 杨1,力源 葛1,争辉 孙1,树栋 张1,国良 王1,晓军 田1,洪宪 张1,*(),潞林 马1,*()   

  • Received:2020-02-27 Online:2022-08-18 Published:2022-08-11
  • Contact: 洪宪 张,潞林 马 E-mail:zwl2006@163.com;malulinpku@163.com
  • Supported by:
    the National Natural Science Foundation of China(81972381)

RICH HTML

   

PDF (PC)

CLC Number: 

  • R737.1

Table 1

Preoperative data of elderly patients with renal cancer and venous tumor thrombus"

Patient number Age/years BMI/(kg/m2) Tumor diameter/ cm Gender Side ASA KPS Clinical symptoms TNM Mayo classification
1 77 22.8 2.0 Male Right 2 100 Local symptoms T4N1M0 Ⅲ
2 82 20.2 10.3 Male Right 2 90 Systemic symptoms T3bN1M0 Ⅰ
3 79 23.3 9.6 Male Left 2 100 Systemic symptoms T3bN0M0 0
4 76 23.9 8.9 Male Left 2 100 Both local and systemic symptoms T3cN0M0 Ⅱ
5 82 17.3 9.2 Male Right 2 100 Local symptoms T3bN1M0 0
6 76 22.6 8.1 Male Right 2 100 Local symptoms T3bN0M0 Ⅰ
7 76 22.8 7.1 Male Left 2 95 None T3bN1M0 Ⅰ
8 75 25.9 4.5 Male Left 3 100 Local symptoms T3bN0M0 0
9 76 24.6 5.0 Male Right 2 80 None T3bN0M0 0
10 83 29.7 7.5 Male Right 3 95 Local symptoms T3bN0M0 Ⅰ
11 75 24.7 7.3 Male Right 3 100 Local symptoms T3bN0M0 Ⅳ
12 75 25.0 6.5 Male Right 3 95 Local symptoms T3bN0M0 Ⅱ

Table 2

Intraoperative and postoperative follow-up data of elderly patients with renal cancer and venous tumor thrombus"

Patient number Preoperative serum creatinine/ (μmol/L) Serum creatinine one week after operation/ (μmol/L) Operative time/min Surgical bleeding volume/mL Surgical blood transfusion volume/mL Plasma transfusion volume/mL Intensive care unit length of stay/d Postoperative hospital stayd/d Inferior vena cava resection Pathology type Postoperative complications Clavien classification system Follow up time/ months Survival state
1 134 117 567 800 0 0 1 13 Yes PC Yes 2 23.0 Dead
2 81 109 313 500 0 0 1 5 No CCC No 0 5.0 Dead
3 84 98 265 400 0 0 0 6 No CCC No 0 44.0 Alive
4 113 74 343 3 500 2 000 0 2 10 Yes CCC No 0 14.0 Dead
5 60 62 174 100 0 0 0 7 No CCC No 0 31.0 Alive
6 128 102 244 1 500 1 200 400 0 6 No CCC No 0 30.0 Alive
7 85 94 399 300 0 0 0 8 No CCC No 0 29.0 Alive
8 99 109 137 200 0 0 0 6 Yes CCC No 0 26.0 Alive
9 69 91 108 20 0 0 0 8 No CCC No 0 25.0 Alive
10 81 109 237 200 0 0 1 7 No CCC No 0 25.0 Alive
11 101 84 320 2 100 2 000 800 1 13 No CCC No 0 Loss to follow up
12 92 161 796 3 200 2 000 1 600 6 6 Yes CCC No 0 15.0 Alive
1 Blute ML , Leibovich BC , Lohse CM , et al. The Mayo clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus[J]. BJU Int, 2004, 94 (1): 33- 41.
doi: 10.1111/j.1464-410X.2004.04897.x
2 Al-Otaibi M , Abou-Youssif T , Alkhaldi A , et al. Renal cell carcinoma with inferior vena caval extention: impact of tumour extent on surgical outcome[J]. BJU Int, 2009, 104 (10): 1467- 1470.
doi: 10.1111/j.1464-410X.2009.08575.x
3 彭希哲, 卢敏. 老年人口死亡概率时代变迁与老年定义的重新思考[J]. 人口与经济, 2017, 221 (2): 1- 10.
4 Han KR , Kim HL , Pantuck AJ , et al. Use of American Society of Anesthesiologists physical status classification to assess perioperative risk in patients undergoing radical nephrectomy for renal cell carcinoma[J]. Urology, 2004, 63 (5): 841- 847.
doi: 10.1016/j.urology.2003.12.048
5 Schag CC , Heinrich RL , Ganz PA . Karnofsky performance status revisited: reliability, validity, and guidelines[J]. J Clin Oncol, 1984, 2 (3): 187- 193.
doi: 10.1200/JCO.1984.2.3.187
6 李丽伟, 刘茁, 王国良, 等. 肾癌伴下腔静脉瘤栓合并血栓的多种影像学比较[J]. 北京大学学报(医学版), 2019, 51 (4): 678- 683.
7 李丽伟, 刘茁, 王国良, 等. 肾癌伴下腔静脉瘤栓: 影像评估模型对下腔静脉切除的应用价值[J]. 现代泌尿外科杂志, 2019, 24 (8): 614- 620.
doi: 10.3969/j.issn.1009-8291.2019.08.004
8 刘茁, 马潞林, 田晓军, 等. 根治性肾切除术+下腔静脉癌栓取出术治疗Mayo 0~Ⅳ级下腔静脉癌栓的临床经验[J]. 中华泌尿外科杂志, 2017, 38 (11): 842- 847.
doi: 10.3760/cma.j.issn.1000-6702.2017.11.010
9 田晓军, 邱敏, 刘茁, 等. 微创手术治疗肾癌合并Mayo 0~2级静脉癌栓的单中心研究[J]. 北京大学学报(医学版), 2018, 50 (6): 1053- 1056.
10 刘茁, 田晓军, 马潞林. 根治性肾切除术联合Ⅱ级静脉癌栓取出术的临床麻醉管理[J]. 现代肿瘤医学, 2017, 25 (16): 2672- 2677.
doi: 10.3969/j.issn.1672-4992.2017.16.038
11 刘茁, 马潞林, 田晓军, 等. 腹腔镜和开放肾癌根治性切除+Ⅱ级下腔静脉癌栓取出术例临床分析[J]. 现代泌尿外科杂志, 2017, 22 (8): 603- 607.
doi: 10.3969/j.issn.1009-8291.2017.08.009
12 马潞林, 刘茁. 肾癌并肝段和肝以上下腔静脉癌栓的诊治体会[J]. 中华泌尿外科杂志, 2017, 38 (7): 481- 484.
doi: 10.3760/cma.j.issn.1000-6702.2017.07.001
13 刘茁, 马潞林, 田晓军, 等. 肾癌根治性切除加癌栓取出术治疗Ⅲ级下腔静脉癌栓的手术技术及临床经验[J]. 北京大学学报(医学版), 2017, 49 (4): 597- 602.
doi: 10.3969/j.issn.1671-167X.2017.04.008
14 Liu Z , Tang S , Tian X , et al. Foley catheter-assisted six-step thrombectomy technique in the surgical management of renal cell carcinoma with Mayo level Ⅱ to Ⅳ tumor thrombus[J]. J Int Med Res, 2019, 47 (5): 2104- 2115.
doi: 10.1177/0300060519836912
15 赵勋, 李丽伟, 刘茁, 等. 根治性肾切除术及下腔静脉癌栓取出术治疗Ⅳ级下腔静脉癌栓的手术技术及临床经验[J]. 现代泌尿外科杂志, 2019, 24 (8): 639- 644.
doi: 10.3969/j.issn.1009-8291.2019.08.009
16 刘茁, 马潞林, 王国良, 等. 肾细胞癌合并下腔静脉癌栓患者发生术后早期并发症的临床分析[J]. 国际外科学杂志, 2016, 43 (9): 598- 602.
doi: 10.3760/cma.j.issn.1673-4203.2016.09.007
17 Mandal S , Sankhwar SN , Kathpalia R , et al. Grading complications after transurethral resection of prostate using modified Clavien classification system and predicting complications using the Charlson comorbidity index[J]. Int Urol Nephrol, 2013, 45 (2): 347- 354.
doi: 10.1007/s11255-013-0399-x
18 Psutka SP , Leibovich BC . Management of inferior vena cava tumor thrombus in locally advanced renal cell carcinoma[J]. Ther Adv Urol, 2015, 7 (4): 216- 229.
doi: 10.1177/1756287215576443
19 Cost NG , Delacroix SE , J r. , Sleeper JP , et al. The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus[J]. Eur Urol, 2011, 59 (6): 912- 918.
doi: 10.1016/j.eururo.2011.02.032
20 Siva S , Pham D , Gill S , et al. A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinomav[J]. BJU Int, 2012, 110 (11 Pt B): E737- E743.
21 Zielinski H , Szmigielski S , Petrovich Z . Comparison of preoperative embolization followed by radical nephrectomy with radical nephrectomy alone for renal cell carcinoma[J]. Am J Clin Oncol, 2000, 23 (1): 6- 12.
doi: 10.1097/00000421-200002000-00002
22 刘茁, 唐世英, 范雯怡, 等. 多学科综合治疗模式在肾癌伴静脉癌栓患者临床诊治中的作用[J]. 现代泌尿外科杂志, 2019, 24 (8): 634- 638.
doi: 10.3969/j.issn.1009-8291.2019.08.008
[1] Fan SHU, Liyuan GE, Hanzhang DENG, Haoming YIN, Junyong OU, Shaohui DENG, Yichang HAO, Min LU, Zhanyi ZHANG, Peichen DUAN, Shudong ZHANG. Molecular characteristics for poor prognosis related renal cell carcinoma with lymph metastases [J]. Journal of Peking University (Health Sciences), 2026, 58(3): 631-640.
[2] Haoming YIN, Zijie WANG, Fan SHU, Zhanyi ZHANG, Hui LIANG, Shudong ZHANG. Expression and significance of the FABP6 long transcript in clear cell renal cell carcinoma [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 393-398.
[3] Shenmo LI, Dandan SU, Jiyu LIN, Haodong SONG, Lulin MA, Xiaofei HOU, Guoliang WANG, Hongxian ZHANG, Jianfei YE, Shudong ZHANG. Prognostic analysis of laparoscopic simultaneous radical cystectomy and nephroureterectomy [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 961-966.
[4] Boda GUO, Min LU, Guoliang WANG, Hongxian ZHANG, Lei LIU, Xiaofei HOU, Lei ZHAO, Xiaojun TIAN, Shudong ZHANG. Clinicopathological and prognostic differences between clear cell and non-clear cell renal cell carcinoma with venous tumor thrombus [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 644-649.
[5] Zhanyi ZHANG, Min LU, Yuehao SUN, Jinghan DONG, Xiaofei HOU, Chunlei XIAO, Guoliang WANG, Xiaojun TIAN, Lulin MA, Hongxian ZHANG, Shudong ZHANG. Clinicopathological features and survival analysis of TFE3-rearranged renal cell carcinoma with venous tumor thrombus [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 650-661.
[6] Qi MIAO, Baoan HONG, Xuezhou ZHANG, Zhipeng SUN, Wei WANG, Yuxuan WANG, Yuxuan BO, Jiahui ZHAO, Ning ZHANG. Risk assessment of perioperative adverse events and management of antiplatelet therapy in patients with bladder cancer and coronary atherosclerotic heart disease undergoing transurethral resection of bladder cancer [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 698-703.
[7] Zezhen ZHOU, Liyuan GE, Fan ZHANG, Shaohui DENG, Ye YAN, Hongxian ZHANG, Guoliang WANG, Lei LIU, Yi HUANG, Shudong ZHANG. A retrospective matching study of partial nephrectomy and radical nephrectomy for pathological T3a stage renal cell carcinoma [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 704-710.
[8] Shuai LIU, Zhuo LIU, Yunhe GUAN, Guoliang WANG, Xiaojun TIAN, Hongxian ZHANG, Lei LIU, Lulin MA, Shudong ZHANG. Robot-assisted laparoscopic inferior vena cava segmental resection for renal tumor with tumor thrombus invading the vascular wall [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 796-802.
[9] Zezhen ZHOU,Shaohui DENG,Ye YAN,Fan ZHANG,Yichang HAO,Liyuan GE,Hongxian ZHANG,Guoliang WANG,Shudong ZHANG. Predicting the 3-year tumor-specific survival in patients with T3a non-metastatic renal cell carcinoma [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 673-679.
[10] Binshuai WANG,Min QIU,Qianjin ZHANG,Maofeng TIAN,Lei LIU,Guoliang WANG,Min LU,Xiaojun TIAN,Shudong ZHANG. Experience in diagnosis and treatment of 6 cases of renal Ewing's sarcoma with venous thrombus [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 636-639.
[11] Jie YANG,Jieli FENG,Shudong ZHANG,Lulin MA,Qing ZHENG. Clinical effects of transesophageal echocardiography in different surgical methods for nephrectomy combined with Mayo Ⅲ-Ⅳ vena tumor thrombectomy [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 631-635.
[12] Kewei CHEN,Zhuo LIU,Shaohui DENG,Fan ZHANG,Jianfei YE,Guoliang WANG,Shudong ZHANG. Clinical diagnosis and treatment of renal angiomyolipoma with inferior vena cava tumor thrombus [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 617-623.
[13] Le YU,Shaohui DENG,Fan ZHANG,Ye YAN,Jianfei YE,Shudong ZHANG. Clinicopathological characteristics and prognosis of multilocular cystic renal neoplasm of low malignant potential [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 661-666.
[14] Fan SHU,Yichang HAO,Zhanyi ZHANG,Shaohui DENG,Hongxian ZHANG,Lei LIU,Guoliang WANG,Xiaojun TIAN,Lei ZHAO,Lulin MA,Shudong ZHANG. Functional and oncologic outcomes of partial nephrectomy for cystic renal cell carcinoma: A single-center retrospective study [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 667-672.
[15] 树栋 张,睿扬 谢. [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 562-564.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd